Clover Meds Review

Our assessment

The figure Clover Meds leads with is a twelve-month rate. Buy a month at a time and you pay materially more. Get past that and the disclosure here is unusually good. One page names the pharmacy that fills the prescription, with a street address, a telephone number, an email and a licensing description. Another lists the clinicians who write it, by name and credential. The price ladder is complete for both drugs, with the plan total printed beside every per-month figure.

A pharmacy you could telephone

The pharmacy-partners page names one compounding pharmacy, describes it as a licensed sterile facility of a stated class, and gives its website, its full street address, its email address and its telephone number. It also says plainly that the pharmacy filling a given prescription may vary, and that whichever one does will be named on the label.

A named facility you can check against a board of pharmacy record, plus an honest note that it may not always be the one, beats a longer list of names with no contact details behind any of them.

Six clinicians, named

A separate page lists the active prescribing clinicians by name and credential. Not a claim about board-certified physicians in general: six people, each of whom you can check against a state license register.

The site also says the price is the same at every dose, so titrating up doesn't quietly change the bill. Between the named pharmacy, the named clinicians and flat dose pricing, three of the questions you would normally have to ask at intake are answered before it.

The headline is the longest plan

Both drug pages lead with a from figure, and on both drugs that figure is the twelve-month tier. The page isn't hiding it. The one-month, three-month, six-month and twelve-month rates are all printed, each with its total. But take the headline as the price of a month and you'll be wrong by a wide margin on both drugs.

Neither priced page says whether a membership fee applies. The pages promise no hidden fees and no price increases, which is a reassurance rather than an answer.

The warning letter

The FDA issued Clover Meds a warning letter in June 2026 over false and misleading claims about compounded medication.

The letter concerns claims the company made about the product. Weigh it as a disclosure alongside everything else here, not as a finding about what is in the vial.